Epoch Innovations

Epoch Innovations is a biotechnology company focused on the development of blood-based diagnostic tests for the early detection of neurodegenerative diseases. Utilizing a proprietary platform developed at Rowan University, the company identifies specific autoantibody signatures in human serum that serve as highly sensitive biomarkers for conditions such as Alzheimer's and Parkinson's disease. These autoantibodies are produced by the immune system in response to early-stage cellular damage in the brain, allowing for detection years before clinical symptoms manifest. The company aims to provide a non-invasive and cost-effective diagnostic tool to facilitate early patient intervention and improve the stratification of participants for clinical trials of neuroprotective therapies. By enabling earlier diagnosis, Epoch Innovations seeks to significantly enhance the management and treatment outcomes for patients with neurodegenerative disorders.